SFC Capital

CareLoop Health, originating from the University of Manchester, offers a digital platform that supports patients with mental health issues. It enables healthcare professionals to remotely monitor and track patient symptoms, while providing patients with personalized resources to manage their conditions. The platform uses predictive analytics to anticipate future mental health problems, helping to prevent escalation or relapse, and ultimately aims to reduce crises in mental health.

AMPED is a biotechnology company that specializes in the production of polymerase chain reaction (PCR) reagents. Its mission is to make PCR technology more accessible and affordable to scientists and innovators. AMPED achieves this by offering high-quality PCR reagents that outperform industry standards at a significantly lower cost. The company's approach includes distributed manufacturing and integrated automation, which further enhance affordability and accessibility.

Chiron offers a revolutionary approach to managing chronic illnesses. Based on the user's profile, it uses AI to suggest tailored self-care treatments that have the highest chance of success. It then offers a straightforward framework for evaluating the results.

The goal of Reneural is to use technology to revolutionize healthcare delivery by increasing its effectiveness, efficiency, and accessibility for both patients and physicians.

Llusern Scientific operates molecular point-of-care testing centers, focusing on urinary tract infection diagnostics. Their innovative product rapidly detects and identifies bacteria, empowering medical professionals to make prompt decisions and enhance patient care.

Medwise.ai offers a customizable search platform designed to support clinical decision-making for healthcare professionals. Utilizing natural language processing and artificial intelligence, the platform enables doctors to efficiently access and organize medical knowledge. By leveraging real-world data, Medwise.ai provides valuable intelligence and insights to various stakeholders within the healthcare ecosystem. This innovative approach aims to enhance the professional capabilities of doctors, ultimately improving patient care and outcomes.

AMPED is a biotechnology company that specializes in the production of polymerase chain reaction (PCR) reagents. Its mission is to make PCR technology more accessible and affordable to scientists and innovators. AMPED achieves this by offering high-quality PCR reagents that outperform industry standards at a significantly lower cost. The company's approach includes distributed manufacturing and integrated automation, which further enhance affordability and accessibility.

Llusern Scientific operates molecular point-of-care testing centers, focusing on urinary tract infection diagnostics. Their innovative product rapidly detects and identifies bacteria, empowering medical professionals to make prompt decisions and enhance patient care.

PulmoBiomed is a developer of innovative sampling technology that offers a non-invasive method for clinicians and researchers to collect biological samples. The company's primary product is a passive fluid aerosol sampler designed to capture exhaled breath condensate and environmental particles, effectively segregating them by size. This technology addresses critical challenges in sample collection, such as preventing contamination and loss, while ensuring the generation of highly reproducible data with digital molecular precision. By focusing on metabolomic profiling and biological agent capture, PulmoBiomed aims to enhance the accuracy and reliability of respiratory diagnostics and research.

Strolll is a digital health startup focused on creating solutions to enhance mobility for individuals with neurological disorders. The company develops extended reality digital therapeutics that empower movement therapy through innovative approaches. Its offerings include augmented reality services designed for cueing therapy and gamified exercise, aimed at improving gait and balance while reducing the risk of falls for patients with conditions such as Parkinson's disease. By providing these therapeutic tools, Strolll enables individuals to better manage their neurological disorders and improve their overall quality of life.

Elaitra specializes in advanced breast cancer detection through its innovative digital breast tomosynthesis imaging technology. The company has developed a generative language model for voice-based patient engagement, alongside a unique AI tool that assists healthcare professionals in interpreting 3D X-rays. Elaitra's solutions enhance early detection and diagnosis by providing a viewing assistant and computer-assisted diagnosis for effective triage. With regulatory approvals from the FDA and UK authorities, Elaitra operates in both the United States and the United Kingdom, aiming to improve patient outcomes in breast cancer treatment.

MedQ is a smart platform that helps healthcare professionals complete assessments using a three-step process: Select-Send-Analyse. It is designed for clinics to transition from paper assessments to remote patient monitoring.

Medwise.ai offers a customizable search platform designed to support clinical decision-making for healthcare professionals. Utilizing natural language processing and artificial intelligence, the platform enables doctors to efficiently access and organize medical knowledge. By leveraging real-world data, Medwise.ai provides valuable intelligence and insights to various stakeholders within the healthcare ecosystem. This innovative approach aims to enhance the professional capabilities of doctors, ultimately improving patient care and outcomes.

Nanovery Limited, founded in 2018 and based in London, United Kingdom, specializes in developing nanorobots aimed at detecting cancer mutations. The company's innovative platform utilizes artificial intelligence to facilitate the rapid and ultra-sensitive identification of challenging biomarkers in blood samples. These nanorobots can capture circulating tumor DNA and emit a fluorescent signal, enabling healthcare professionals to conduct point-of-care tests. By facilitating early cancer detection, Nanovery aims to enhance patient outcomes and increase survival rates. The organization is supported by a team of experts in nanotechnology, medicinal chemistry, and artificial intelligence, along with backing from leading academics, clinicians, and industry leaders.

Hormona is dedicated to transforming hormonal health for women through innovative home testing and artificial intelligence. By offering an end-to-end solution, the company provides women with a unique approach to understanding and managing their hormone levels. Supported by a team of leading endocrinologists, gynecologists, and nutritionists, Hormona ensures that its testing methods are safe, accurate, and convenient. Users can monitor their hormones from home using a pain-free testing process, which seamlessly integrates with the Hormona app. This platform empowers women to take control of their health by enabling them to track their hormone levels daily and gain valuable insights, ultimately enhancing their overall well-being.

Strolll is a digital health startup focused on creating solutions to enhance mobility for individuals with neurological disorders. The company develops extended reality digital therapeutics that empower movement therapy through innovative approaches. Its offerings include augmented reality services designed for cueing therapy and gamified exercise, aimed at improving gait and balance while reducing the risk of falls for patients with conditions such as Parkinson's disease. By providing these therapeutic tools, Strolll enables individuals to better manage their neurological disorders and improve their overall quality of life.

Hormona is dedicated to transforming hormonal health for women through innovative home testing and artificial intelligence. By offering an end-to-end solution, the company provides women with a unique approach to understanding and managing their hormone levels. Supported by a team of leading endocrinologists, gynecologists, and nutritionists, Hormona ensures that its testing methods are safe, accurate, and convenient. Users can monitor their hormones from home using a pain-free testing process, which seamlessly integrates with the Hormona app. This platform empowers women to take control of their health by enabling them to track their hormone levels daily and gain valuable insights, ultimately enhancing their overall well-being.

Elaitra specializes in advanced breast cancer detection through its innovative digital breast tomosynthesis imaging technology. The company has developed a generative language model for voice-based patient engagement, alongside a unique AI tool that assists healthcare professionals in interpreting 3D X-rays. Elaitra's solutions enhance early detection and diagnosis by providing a viewing assistant and computer-assisted diagnosis for effective triage. With regulatory approvals from the FDA and UK authorities, Elaitra operates in both the United States and the United Kingdom, aiming to improve patient outcomes in breast cancer treatment.

Strolll is a digital health startup focused on creating solutions to enhance mobility for individuals with neurological disorders. The company develops extended reality digital therapeutics that empower movement therapy through innovative approaches. Its offerings include augmented reality services designed for cueing therapy and gamified exercise, aimed at improving gait and balance while reducing the risk of falls for patients with conditions such as Parkinson's disease. By providing these therapeutic tools, Strolll enables individuals to better manage their neurological disorders and improve their overall quality of life.

Nanovery Limited, founded in 2018 and based in London, United Kingdom, specializes in developing nanorobots aimed at detecting cancer mutations. The company's innovative platform utilizes artificial intelligence to facilitate the rapid and ultra-sensitive identification of challenging biomarkers in blood samples. These nanorobots can capture circulating tumor DNA and emit a fluorescent signal, enabling healthcare professionals to conduct point-of-care tests. By facilitating early cancer detection, Nanovery aims to enhance patient outcomes and increase survival rates. The organization is supported by a team of experts in nanotechnology, medicinal chemistry, and artificial intelligence, along with backing from leading academics, clinicians, and industry leaders.

Medwise.ai offers a customizable search platform designed to support clinical decision-making for healthcare professionals. Utilizing natural language processing and artificial intelligence, the platform enables doctors to efficiently access and organize medical knowledge. By leveraging real-world data, Medwise.ai provides valuable intelligence and insights to various stakeholders within the healthcare ecosystem. This innovative approach aims to enhance the professional capabilities of doctors, ultimately improving patient care and outcomes.

CircaGene Ltd is a London-based company that specializes in bioinformatics and genetic testing. Founded in 2018, it offers a direct-to-consumer platform where individuals can order personal DNA tests while ensuring total privacy through patented end-to-end encryption. CircaGene's services include comprehensive DNA sequencing that identifies hereditary health risks and provides actionable health reports. The platform is designed to be user-friendly, allowing consumers to easily navigate their genetic results and connect with healthcare providers. By enabling users to access and understand their genomic data, CircaGene empowers individuals to take proactive measures to enhance their health and lifestyle.

Medtech

Algocyte is a company based in Reading, United Kingdom, that provides a comprehensive, medically-driven solution for remote blood testing and health monitoring. The company enables medical professionals to remotely track and assess patients with various conditions, including leukemia, anemia, infections, inflammation, autoimmune disorders, and other blood cell-related issues. Algocyte's medical device conducts a range of hematological and biochemical tests, allowing for a more detailed profile of an individual's health by analyzing data over time rather than relying on isolated tests. This approach enhances risk assessment and decision support for healthcare providers.

Whiterabbit.ai is a company focused on developing artificial intelligence-driven software designed to improve the early detection of cancer, particularly breast cancer. Its platform aims to transform the screening and diagnostic process by addressing key challenges throughout the cancer screening journey. This includes enhancing patient compliance and improving the accuracy of healthcare providers, ultimately leading to better patient outcomes. By leveraging advanced technology, Whiterabbit.ai seeks to engage patients effectively and elevate the overall quality of care in cancer detection.

Intoolab LTD, founded in 2016 and based in London, develops an artificial intelligence platform known as Tzager. This platform is designed for researchers, R&D professionals, professors, and students engaged in biomedical research, drug discovery, and personalized medicine. Tzager serves as a comprehensive Bayesian Inference framework, distinguishing itself as the first of its kind in Python, and offers features such as biochemical analysis, predictor research and models, and literature intelligence. Unlike conventional deep learning algorithms, Tzager employs a framework based on causal equations and Bayesian networks, enabling it to emulate human understanding of biomedicine through causal reasoning. This unique capability allows Tzager to provide insightful analysis and suggestions tailored to the specific needs of its users, facilitating collaboration across various scientific fields.

ORB Innovations is a deep tech digital health platform focused on delivering high-quality biometric data and insights to enhance users' health and well-being. The company has developed a smart mouthguard device that monitors head movements to prevent misdiagnosed injuries in sports. This innovative device employs wearable technology, including accelerometers, gyroscopes, and magnetometers, to track the forces experienced by athletes. By providing detailed reports on these metrics, ORB Innovations enables athletes to monitor their health, prevent injuries, and optimize their recovery processes. Through its products, the company aims to empower users to lead healthier and happier lives.

Jupiter Diagnostics is a company that specializes in innovative blood testing solutions utilizing patented nano crystal labeled technology. This technology allows for the rapid processing of multiple blood tests from a simple finger prick, delivering results within 10 minutes and at a cost significantly lower than traditional laboratory testing. By providing high-quality and affordable diagnostics, Jupiter Diagnostics aims to enhance the accessibility of medical testing for both clinicians and patients. Their intuitive testing process simplifies blood sample collection, facilitating quicker decision-making for healthcare practitioners and ultimately improving patient care.

TrooFoods is a company focused on enhancing gut health through the production of prebiotic-rich food products. By offering freshly made granola, TrooFoods aims to inspire individuals to improve their diets for better physical and mental wellbeing. The company emphasizes the importance of nourishing good gut bacteria, which is essential for overall health. Through its nutritious and delicious offerings, TrooFoods seeks to promote long, healthy, and happy lives for its customers.

Numeration Systems Ltd specializes in creating detailed health and wellbeing operational models along with various web-based tools aimed at enhancing healthcare services. Established in 2013 and located in Truro, United Kingdom, the company focuses on key areas such as service repatriation, demand and capacity planning, carbon footprint modeling, and benchmarking for integrated care. In addition to its modeling solutions, Numeration Systems offers consultancy services to assist organizations in effectively redesigning their healthcare operations based on quantitative data.

Rocking the tea world with a range of vitamin enriched super green teas.

Numeration Systems Ltd specializes in creating detailed health and wellbeing operational models along with various web-based tools aimed at enhancing healthcare services. Established in 2013 and located in Truro, United Kingdom, the company focuses on key areas such as service repatriation, demand and capacity planning, carbon footprint modeling, and benchmarking for integrated care. In addition to its modeling solutions, Numeration Systems offers consultancy services to assist organizations in effectively redesigning their healthcare operations based on quantitative data.

FindMe Health is an online platform designed to empower patients by providing access to reliable and comparable information on the quality and pricing of healthcare services. Targeting individuals who are seeking alternatives to NHS treatment, especially when they are ineligible or facing long waiting times, the platform allows users to compare hospital consultants based on various criteria such as procedure volume, patient feedback, hospital location, and treatment costs. This comprehensive comparison helps patients make informed decisions regarding their healthcare options. In addition to offering detailed insights on conditions, hospitals, and consultants, FindMe Health facilitates the booking of initial consultations directly through the site. By consolidating essential information in one place, it aims to simplify the often confusing landscape of self-pay healthcare and enable patients to take control of their health decisions.

Eupnoos is a health-tech company specializing in digital healthcare solutions for lung health and disease detection. The company has developed a smartphone-based application that utilizes the device's microphone and camera to perform clinical-grade lung function tests and symptom-guided assessments. This platform enables users to screen, measure, and track the progression of lung health issues. By providing device-agnostic, API-accessible automated testing and data interpretation, Eupnoos supports both clinical and consumer-grade respiratory monitoring devices. The company's services facilitate telehealth and remote patient monitoring, empowering individuals to gain insights into their lung health and access professional healthcare guidance.